Alligator Bioscience
Develops immuno-oncology antibody drugs for cancer, with a lead candidate for pancreatic cancer.
ATORX | ST
Overview
Corporate Details
- ISIN(s):
- SE0000767188 (+8 more)
- LEI:
- 549300E15VI0MB7LXV19
- Country:
- Sweden
- Address:
- C/O Medicon Village, 223 81 Lund
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Alligator Bioscience is a clinical-stage biotechnology company focused on developing tumor-directed immuno-oncology antibody drugs. The company specializes in creating antibody-based pharmaceuticals for cancer treatment, with a primary focus on activating the CD40 receptor pathway to stimulate a patient's immune system against tumors. Its lead candidate, mitazalimab, is a CD40 agonist in late-stage clinical development for pancreatic cancer. Alligator Bioscience's business model is centered on advancing its pipeline of novel drug candidates through discovery, preclinical, and clinical development stages to commercialization.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Alligator Bioscience and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-17 15:00 |
Share Issue/Capital Change
Alligator Bioscience AB announces final outcome of exercise of warrants series …
|
English | 65.7 KB | |
| 2025-09-17 15:00 |
Share Issue/Capital Change
Alligator Bioscience AB meddelar slutligt utfall för nyttjandet av teckningsopt…
|
Swedish | 65.6 KB | |
| 2025-09-16 11:45 |
Share Issue/Capital Change
Alligator Bioscience AB announces preliminary outcome of exercise of warrants s…
|
English | 65.5 KB | |
| 2025-09-16 11:45 |
Share Issue/Capital Change
Alligator Bioscience AB meddelar preliminärt utfall för nyttjandet av tecknings…
|
Swedish | 65.1 KB | |
| 2025-09-11 08:30 |
Share Issue/Capital Change
Sista dag för handel med teckningsoptioner serie TO 13 i Alligator Bioscience ä…
|
Swedish | 67.7 KB | |
| 2025-09-11 08:30 |
Share Issue/Capital Change
Last day of trading in warrants series TO 13 in Alligator Bioscience is 11 Sept…
|
English | 67.2 KB | |
| 2025-09-08 22:10 |
Capital/Financing Update
Alligator Bioscience has renegotiated the outstanding loan from Fenja Capital a…
|
English | 71.6 KB | |
| 2025-09-08 22:10 |
Capital/Financing Update
Alligator Bioscience har omförhandlat det utestående lånet från Fenja Capital o…
|
Swedish | 71.7 KB | |
| 2025-08-27 21:00 |
Share Issue/Capital Change
Exercise price determined for the exercise of warrants series TO 13 in Alligato…
|
English | 72.6 KB | |
| 2025-08-27 21:00 |
Share Issue/Capital Change
Teckningskurs fastställd för nyttjandet av teckningsoptioner serie TO 13 i Alli…
|
Swedish | 72.8 KB | |
| 2025-07-21 12:18 |
Major Shareholding Notification
|
Swedish | 10.9 KB | |
| 2025-07-17 11:38 |
Major Shareholding Notification
|
Swedish | 10.9 KB | |
| 2025-07-10 10:49 |
Major Shareholding Notification
|
Swedish | 10.9 KB | |
| 2025-07-10 08:00 |
Interim Report
|
Swedish | 1.2 MB | |
| 2025-07-10 08:00 |
Interim Report
|
English | 1.2 MB |
Automate Your Workflow. Get a real-time feed of all Alligator Bioscience filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Alligator Bioscience via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-28 | Peter Ostler | Other | Sell | 1,658,134 | 179,045.31 SEK |
| 2024-04-11 | Staffan Encrantz | Other | Sell | 44,108,581 | 47,196,181.67 SEK |
| 2022-10-27 | Sören Bregenholt Frederiksen | Other | Buy | 52,000 | 72,748.00 SEK |
| 2022-10-25 | Marie Svensson | Other | Buy | 12,000 | 16,632.00 SEK |
| 2022-08-19 | Sören Bregenholt Frederiksen | Other | Buy | 13,906 | 25,726.10 SEK |
| 2022-08-18 | Sören Bregenholt Frederiksen | Other | Buy | 31,094 | 56,911.35 SEK |
| 2022-05-31 | Peter Ostler | Other | Buy | 100,000 | 151,500.00 SEK |
| 2022-05-04 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 50,895.00 SEK |
| 2022-05-02 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 50,811.00 SEK |
| 2022-04-30 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 51,171.00 SEK |
